Ionis Pharmaceuticals

10 Decision Makers · 10 Verified Contacts

📍 Carlsbad, California, United StatesBiotechnology🗓 Est. 1989👥 251–500 employees

About Ionis Pharmaceuticals

Ionis Pharmaceuticals specializes in the discovery and development of RNA-targeted drugs.

Leadership & Decision Makers

Contact details of 10 Ionis Pharmaceuticals decision makers

Meghdad Rahdar

Assistant Director

Brent Golec

Executive Director, Pharmaceutical Development

Eugene Schneider

EVP and Chief Clinical Development Officer

Patrick R. O’Neil

Senior Vice President, Legal and General Counsel

Eric Bastings

Vice President, Development Strategy

Michael Tanowitz

Director

Stanley Crooke

Executive Chairman

Claus Rentel

Director, Analytical Development / Quality Control

Christopher K. Mirabelli

Founder

Daniel Ripley

Founder

General Emails

General company emails, e.g. customer support lines

    marketing@ionispharma.com

    Marketing Team

    sales@ionispharma.com

    Sales Department

    pierre_chevallier@ionispharma.com

    Unclassified inbox

Similar Companies like Ionis Pharmaceuticals

Jazz Pharmaceuticals

jazzpharma.com
Biotechnology · Palo Alto, CA · Est. 2003 · 501–1000 employees · $500M–$1B

HQ: Palo Alto, CA

Sorrento Therapeutics

sorrentotherapeutics.com
Pharmaceuticals · San Diego, CA · Est. 2006 · 101–250 employees · $500M–$1B

HQ: San Diego, CA

Moderna

modernatx.com
Biotechnology · Cambridge, MA · Est. 2010 · 1001–5000 employees

HQ: Cambridge, MA

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Biotechnology · Boston, MA · Est. 1989 · 1001–5000 employees · $500M–$1B

HQ: Boston, MA

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 27/07/2025

(760)931-9200

Carlsbad, California, United States

Legal Name: Ionis Pharmaceuticals, Inc.
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Debt
Founded Date: 1989
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:IONS
Operating Status: Active
Last Funding Type: Post-IPO Debt
Phone Number: (760)931-9200
Last Investment Activity: Feb 29, 2024
Investments Activity: Feb 29, 2024 Feb 21, 2024 Feb 14, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.